News Roundup: August 22 to August 26
Your weekly roundup of the latest news from Drug Topics®.
FDA EUA Sought by Pfizer-BioNTech for Omicron Booster
Pfizer-BioNTech hopes booster can be available for use this fall.
Plan for Monkeypox Vaccine Production Released by Federal Officials
Domestic production to begin at Michigan-based pharmaceutical maker.
Immune Health Supplements May Not Be What They Seem
Consumers are purchasing dietary supplements that support or boost the immune system like never before.
FDA Expands Novavax EUA for Use in Adolescents Aged 12 to 17
The vaccine was previously authorized under an EUA for adults aged 18 and older.
Using NSAIDs Tied to Risk of Heart Failure in Patients with Type 2 Diabetes
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.
